Gurtej Singh, MD, a physical medicine and rehabilitation physician, connected with Becker's to answer, "Are orthobiologics overhyped?"
Ask Orthopedic Surgeons is a weekly series of questions posed to surgeons around the country about clinical, business and policy issues affecting orthopedic care. We invite all orthopedic surgeon and specialist responses.
Next question: How can surgeons work to un-silo the orthopedic industry?
Please send responses to Riz Hatton at rhatton@beckershealthcare.com by 5 p.m. CDT Thursday, July 20.
Note: This response has been lightly edited for length and clarity.
Dr. Gurtej Singh: Yes and no — it depends on who is doing the hyping. Overall, orthobiologics are not overhyped. This type of treatment has been established as being safe and effective in the well-selected patient. The proper use of leukocyte-rich or leukocyte-poor PRP formulations, minimally manipulated adipose, or bone marrow concentrate has shown benefit in many common orthopedic injuries.
On the other hand, "regenerative medicine" is not a proper description of these treatments. Advertisements that suggest cartilage, tendon or spinal discs can "regrow" are extremely misleading and medically false. Patients should consult with their doctors to ensure they pursue the treatment best for them rather than the treatment receiving the most hype.